Regulation

Scott Loughlin, partner at Hogan Lovells, discusses the Federal Trade Commission's recent enforcement action against GoodRx and what digital health companies should learn from the case.

In a proposed order, the online therapy company would also pay $7.8 million for allegedly sharing consumer data with third parties like Facebook and Snapchat for advertising purposes.

The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.

Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.

Rapid RV/LV uses AI to calculate the ratio between the right and left ventricles, an indicator of pulmonary embolism severity.

Data is collected via a sensor on a user's chin during sleep and analyzed using AI to aid in diagnosing sleep apnea or other sleep-related conditions.

According to the state authorities, the online birth control company billed Medi-Cal for services it didn't provide and dispensed female condoms to beneficiaries who didn't request them.

Hospital leaders must focus on improving operations, building new revenue streams, and preventing regulatory risk, according to Nioura Ghazni, a partner in the corporate practice group of Sheppard Mullin’s San Francisco office.

Robert Anderson, Jr., CEO of Cyber Defense Labs, on how healthcare organizations protect themselves against cyberattacks, federal technology resources, policy implications and the complexities of cyberinsurance.

The Oregon Health Authority said the deal is not likely to greatly reduce access to affordable care in the state, but it placed some conditions on its approval.